Vertex shares are up on positive FDA News

Vertex shares are up on positive FDA News

Vertex Pharmaceuticals (VRTX) shares are higher after the US Food and Drug Administration said the drug maker's hepatitis C drug treated successfully the majority of patients with the disease in less time than existing medicines, the AP reported. Vertex shares are up 10.7%, or .16, to .20.
Video Rating: 0 / 5

Explains the prevention, causes, symptoms, modes of transmission, and treatment of hepatitis C.

---

Orignal From: Vertex shares are up on positive FDA News